Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,368 | Dovepress* | 9,166+ | 1,657 | 10,823 | |
| PubMed Central* | 4,202 | 1,134 | 5,336 | ||
| Totals | 13,368 | 2,791 | 16,159 | ||
| *Since 23 July 2019 | |||||
View citations on PubMed Central and Google Scholar